Investor's Champion
How to make your money go further

IS Pharma : Variquel® approval and management continues to shine

23/11/2009 · IS Pharma (ISPH) 
IS Pharma (LSE: ISPH), the international speciality pharmaceutical company, and a real star EIS qualifying issue from 2007 continues to deliver.
Today the group announced that marketing authorizations (‘MAs’) for Variquel,a key product for the group, have now been received for all of the major European markets. IS Pharma acquired Variquel in April 2008 when it was marketed only in Germany, Austria and Switzerland. They have since successfully completed the European Mutual Recognition Procedure and subsequently obtained the abovementioned MAs, which has enabled IS Pharma to launch Variquel in the UK, France, Ireland, Denmark, Netherlands, Portugal, Sweden and Finland. Variquel is a rapid-acting vasoconstrictor used in the treatment of oesophageal varices the global market for which is estimated at between £50m…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login